4//SEC Filing
LOSCALZO JOSEPH 4
Accession 0000874015-25-000271
CIK 0000874015other
Filed
Nov 2, 7:00 PM ET
Accepted
Nov 3, 8:14 PM ET
Size
8.7 KB
Accession
0000874015-25-000271
Insider Transaction Report
Form 4
LOSCALZO JOSEPH
Director
Transactions
- Sale
Common Stock
2025-10-31$75.10/sh−16,000$1,201,669→ 36,330 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-10-31−16,000→ 0 totalExercise: $52.22From: 2018-07-03Exp: 2027-07-02→ Common Stock (16,000 underlying) - Exercise/Conversion
Common Stock
2025-10-31$52.22/sh+16,000$835,520→ 52,330 total
Footnotes (2)
- [F1]Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on August 13, 2024.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.00 to $75.47 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) on this Form 4.
Documents
Issuer
IONIS PHARMACEUTICALS INC
CIK 0000874015
Entity typeother
Related Parties
1- filerCIK 0001276128
Filing Metadata
- Form type
- 4
- Filed
- Nov 2, 7:00 PM ET
- Accepted
- Nov 3, 8:14 PM ET
- Size
- 8.7 KB